Search results

  1. Psoriasis

    Everything NICE has said on psoriasis in an interactive flowchart

  2. Perioperative care

    Everything NICE has said on perioperative care in adults in an interactive flowchart.

  3. Idiopathic pulmonary fibrosis

    Everything NICE has said on diagnosing and managing suspected idiopathic pulmonary fibrosis in adults in an interactive flowchart

  4. Familial breast cancer

    Everything NICE has said on assessing and managing familial breast cancer and related risks in people with a family history in an interactive flowchart

  5. Foot care for people with diabetes

    Everything NICE has said on preventing and managing foot problems in children, young people and adults with type 1 or 2 diabetes in an interactive flowchart

  6. Fertility

    Everything NICE has said on assessing and treating people with fertility problems in an interactive flowchart

  7. Non-Hodgkin's lymphoma

    Everything NICE has said on diagnosing and managing non-Hodgkin's lymphoma in adults and young people 16 years and older in an interactive flowchart

  8. Faecal incontinence

    Everything NICE has said on managing faecal incontinence in adults in an interactive flowchart

  9. In those patients with a new diagnosis of hypertension or type 2 diabetes aged 25-84 years, recorded between the preceding 1 April to 31 March (excluding those with pre-existing CHD, stroke and/or TIA), who have a recorded CVD risk assessment score (using the QRISK2 assessment tool) of more than 20% in the preceding 12 months: the percentage who are currently treated with statins (unless there is a contraindication)

    In those patients with a new diagnosis of hypertension or type 2 diabetes aged 25-84 years, recorded between the preceding 1 April to 31 March...

  10. Sarcoma

    Everything NICE has said on sarcoma in an interactive flowchart

  11. Lower limb peripheral arterial disease

    Everything NICE has said on diagnosing and managing lower limb peripheral arterial disease in an interactive flowchart

  12. Obesity

    Everything NICE has said on preventing, identifying, assessing and managing obesity in an interactive flowchart

  13. Age-related macular degeneration

    Everything NICE has said on age-related macular degeneration in an interactive flowchart

  14. Brain tumours and metastases

    Everything NICE has said on brain tumours in adults, including cancer, in an interactive flowchart

  15. Suspected cancer recognition and referral

    Everything NICE has said on suspected cancer, recognition and selection for referral or investigation in primary care in an interactive flowchart

  16. Cervical cancer

    Everything NICE has said on screening and managing cervical cancer in an interactive flowchart

  17. Abortion care

    Everything NICE has said on abortion care in an interactive flowchart.

  18. Abortion care (QS199)

    This quality standard covers care for women of any age (including girls and young women under 18) who request an abortion. It describes high-quality care in priority areas for improvement.

  19. Venous thromboembolism in adults: diagnosis and management (QS29)

    This quality standard covers diagnosing and treating venous thromboembolism (VTE) in adults. VTE includes deep vein thrombosis (DVT) and pulmonary embolism. It describes high-quality care in priority areas for improvement.

  20. Develop and validate new and existing screening tools (including physical, psychological and psychiatric aspects) for post-COVID-19 syndrome in a UK population. What tools are validated for screening for post‑COVID‑19 syndrome, which are the most accurate at identifying post‑COVID‑19 syndrome in a UK population and what is their effectiveness in guiding management?

    Recommendation ID NG188/7 Question Develop and validate new and existing screening tools (including physical, psychological and

  21. What are the most clinically effective interventions (including social prescribing and structured community support) for managing post‑COVID‑19 syndrome? Does effectiveness vary for different population groups (for example sex, age, socioeconomic group, black, Asian and minority ethnic group communities or people with learning disabilities)? Do any symptoms of post‑COVID‑19 syndrome predict the need for specialist intervention? Are there clusters of symptoms that identify response to interventions in post‑COVID‑19 syndrome? What is the clinical effectiveness of different service models of multimodality/multidisciplinary post‑COVID‑19 syndrome rehabilitation in improving patient‑reported outcomes (such as quality of life)? What is the clinical effectiveness of exercise interventions for people with post‑COVID‑19 syndrome? Does effectiveness vary for different population groups (for example sex, age, socioeconomic group, black, Asian and minority ethnic group communities or people with learning disabilities)? Does early exercise rehabilitation assist in improving symptoms of post‑COVID‑19 syndrome?

    Recommendation ID NG188/2 Question What are the most clinically effective interventions (including social prescribing and structured community

  22. Evidence on the safety and efficacy of balloon cryoablation for squamous dysplasia of the oesophagus is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research. This could be in the form of randomised controlled trials or published registry data.   Find out  what only in research means on the NICE interventional procedures guidance page .

    Recommendation ID IPG683/1 Question Evidence on the safety and efficacy of balloon cryoablation for squamous dysplasia of the oesophagus

  23. Evidence on the safety and efficacy of balloon cryoablation for Barrett's oesophagus is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research. This could be in the form of randomised controlled trials or published registry data.   Find out  what only in research means on the NICE interventional procedures guidance page .

    Recommendation ID IPG682/1 Question Evidence on the safety and efficacy of balloon cryoablation for Barrett's oesophagus is inadequate

  24. Evidence on the safety of the swallowable gastric balloon capsule for weight loss shows infrequent but potentially serious adverse events: For people who need to lose weight in the short term for medical reasons, the evidence of efficacy is adequate to support the use of this procedure provided that special arrangements are in place for clinical governance, consent and audit.  Find out  what special arrangements mean on the NICE interventional procedures guidance page . For people who are aiming for long-term weight loss, the evidence on efficacy is inadequate in quantity and quality, so the procedure should only be used in the context of research.   Find out  what only in research means on the NICE interventional procedures guidance page .

    Recommendation ID IPG684/1 Question Evidence on the safety of the swallowable gastric balloon capsule for weight loss shows infrequent

  25. Evidence on the safety of pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis shows that this procedure can cause serious but well-recognised side effects. Evidence on its efficacy is inadequate in quality. Therefore, this procedure should only be used in the context of research. Find out what  only in research means on the NICE website .

    Recommendation ID IPG681/1 Question Evidence on the safety of pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis

  26. Suspected neurological conditions: recognition and referral (QS198)

    This quality standard covers assessing and referring children (under 16) and adults (16 and over) who have symptoms or signs associated with neurological conditions. It describes high-quality care in priority areas for improvement.

  27. Early and locally advanced breast cancer

    Everything NICE has said on diagnosing and treating early and locally advanced breast cancer in an interactive flowchart